Diabetes Type I: Current Modalities of Treatment
Tracking # 20-650663
Course overview
Type 1 diabetes mellitus is a chronic, autoimmune disease that occurs due to pancreas beta cell destruction and insulin deficiency. Symptoms of type 1 diabetes result from high levels of blood glucose which is also known as hyperglycemia. Type 1 diabetes generally begins in children and adolescents however can also develop later on in adults. The etiology of type 1 diabetes remains unknown however it is widely believed to develop because of T cell-mediated destruction of beta cells and autoantibody activity that affect the production of insulin. Environmental triggers and genetic factors will influence the type of autoantibody that influences disease progression. A cure for diabetes is currently not available and disease management depends on lifelong insulin injections. Varied approaches to insulin administration may be introduced to type 1 diabetics, including continuous glucose monitoring and insulin pumps. Treatment options related to type 1 diabetes and several case studies are discussed. No Test Required!
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Certified Nurse Midwife
Certified Nurse Practitioner
Certified Registered Nurse Anesthetist
Clinical Nurse Specialist
Licensed Practical Nurse
Licensed Psychiatric Technician Nurse
Registered Nurse
Registered Nurse Practitioner
District of Columbia Board of Nursing
Certified Nurse Midwife
Clinical Nurse Specialist
Licensed Practical Nurse
Nurse Practitioner
Registered Nurse
Registered Nurse Anesthetist
Florida Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
Georgia Board of Nursing
Licensed Practical Nurse
Registered Professional Nurse
New Mexico Board of Nursing
Certified Nurse Practitioner
Certified Registered Nurse Anesthetist
Clinical Nurse Specialist
Licensed Practical Nurse
Registered Nurse
South Carolina Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
West Virginia Board of Registered Nurses
Advanced Practice Registered Nurse
Registered Nurse
Disclosure statements
Policy Statement
This activity has been planned and implemented in accordance with the policies of NurseCe4Less.com and the continuing nursing education requirements of the American Nurses Credentialing Center's Commission on Accreditation for registered nurses.
Continuing Education Credit Designation
This educational activity is credited for 2.5 hours at completion of the activity. Pharmacology content is 1 hour.
Statement of Learning Need
In type 1 diabetes a person’s body does not produce insulin and clinicians need to be educated and continuously updated on ways the body breaks down nutrients into blood sugar for energy. Conventional and new insulin therapy treatments are available to help patients live in good health.
Course Purpose
To inform health clinicians of the recognition, diagnosis and treatment of diabetes type 2.
Target Audience
Advanced Practice Registered Nurses, Registered Nurses, and other Interdisciplinary Health Team Members.
Disclosures
Kellie Wilson, PharmD, William Cook, PhD, Douglas Lawrence, MA, Susan DePasquale, MSN, FPMHNP-BC – all have no disclosures. There is no commercial support.